NiKang Therapeutics
Wilmington
About NiKang Therapeutics
NiKang Therapeutics is an early-stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is informed by target structure biology and capitalizes on structure-based drug design enabling a rapid and efficient discovery and development of proprietary drug candidates with the most desirable pharmacological features into clinical studies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $260.0M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2021)
- Website: nikangtx.com
- Phone: 302 644 5450
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/nikang-therapeutics-47230 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.